PharmaShots | Incisive News in 3 Shots

Subscribe Now

Idera

Idera Stops P-II (INTRIM 1) Trial of Tilsotolimod (IMO-2125) Due to Positive Efficacy in Patients with Melanoma

Idera Stops P-II (INTRIM 1) Trial of Tilsotolimod (IMO-2125) Due to Positive Efficacy in Patients with Melanoma

May 18, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us